FridayOct 07, 2022 12:20 pm

QualityStocksNewsBreaks – FuelPositive Corporation’s (TSX.V: NHHH) (OTCQB: NHHHF) Green Ammonia System Poised to Offer Supply and Price Stability

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian clean energy and fertilizer solutions innovator, began accepting pre-sale applications for its technological solution that addresses the cuts in fertilizer production by European producers. The solution is “an on-site modular system for producing green, hydrogen-dense ammonia that farmers and other potential end users can adopt to locally generate and manage fertilizer and fuel without reliance on the vagaries of the fertilizer and fuel supply chain,” a recent article reads. “The containerized green ammonia production system created by FuelPositive is currently being built for a pilot project on the Manitoba crop farm of Tracy…

Continue Reading

FridayOct 07, 2022 11:50 am

QualityStocksNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Featured in FedEx Video Presentation

Aditxt (NASDAQ: ADTX), a biotech innovation company, has announced that its AditxtScore(TM) is featured by FedEx in a video presentation that showcases the various ways in which both companies are playing critical roles in a challenging environment that includes the nation’s response to COVID-19. In the clip, the Aditxt team provides a virtual tour of its AditxtScore(TM) Center and describes the company’s collaboration with scientists and technicians to process samples from around the country to help physicians and health care professionals identify and understand their patients’ immune status. “Aditxt is a biotech innovation company with a very special mission —…

Continue Reading

FridayOct 07, 2022 11:34 am

QualityStocksNewsBreaks – Tingo Inc. (TMNA), MICT Inc. (NASDAQ: MICT) Enter Merger Agreement for Acquisition

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, and MICT Inc. (NASDAQ: MICT), have signed a merger agreement outlining plans for MICT to acquire 100% of the operating business and assets of Tingo. According to the announcement, the new merger with the accompanying MICT funding should expedite the launch of Tingo’s food-produce export business; existing high-margin and material export contracts will allow a substantial portion of Tingo’s revenues to shift directly into U.S. dollars. In an amendment, the two companies accelerated and restated the original agreement and merger plan. The transaction will also support the acceleration of the development and…

Continue Reading

FridayOct 07, 2022 11:11 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Advancement of Berubicin Clinical Trial Featured in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio release covers CNS Pharmaceuticals’ recent announcement that highlights the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of glioblastoma multiforme (“GBM”), one of the…

Continue Reading

ThursdayOct 06, 2022 2:31 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Elevating Performance with Expanded Team

Flora Growth Corp. (NASDAQ: FLGC), throughout 2022, has been implementing its hiring strategy that has seen the appointment of several key individuals whose proven talents and productivity are critical to the company’s goal of delivering the most compelling customer experiences. “Flora Growth ushered in the new year with the appointment of Tim Leslie as chairman of its newly formed advisory board. It would later bring Derek Pedro, an industry-leading cannabis genetics and cultivation expert, on board as an advisor and named Vessel founder James Choe as chief strategy officer. In February 2022, Flora Growth announced the appointment of Jessie Casner…

Continue Reading

ThursdayOct 06, 2022 2:14 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Redefining Drug Delivery Platforms

Lexaria Bioscience Corp. (NASDAQ: LEXX) has remained committed to improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream. “Moreover, as a global innovator in drug delivery platforms, the company has not shied away from advancing its research to cut across various health conditions, including but not limited to hypertension, epilepsy, diabetes, and dementia, among others. These efforts have yielded 27 granted patents around the world since 2014, with approximately 50 additional patents pending. It also has national filings in over 40 jurisdictions with the highest commercial potential, reflecting the company’s commitment to creating shareholder value and pushing its technology…

Continue Reading

ThursdayOct 06, 2022 1:59 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Lays Foundation for Significantly Expanded Manufacturing, Distribution Infrastructure

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, recently signed a management services agreement (“MSA”), marking a key milestone as the company actively strengthens its position in the California cannabis space. “SGMD signed the MSA through its subsidiary, SugarRush, which entered into the agreement with Canndis Inc., a California cannabis micro license holder. Canndis holds a license that covers delivery, manufacturing, distribution, and cultivation rights, and the agreement will enable Sugarmade to expand its manufacturing and distribution footprint,” a recent article reads. “Sugarmade is anticipating harvesting [its first crop], an accomplishment made possible through the company’s acquisition…

Continue Reading

ThursdayOct 06, 2022 1:09 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Participate at Upcoming Dawson James Small Cap Growth Conference

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is scheduled to participate in the 7th annual Dawson James Small Cap Growth Conference. Silo Pharma CEO Eric Weisblum will present at the event, which is scheduled for Oct. 12, 2022, in Jupiter, Florida. Weisblum’s presentation will include an overview of Silo Pharma’s acquisition and development of intellectual property and technology rights from leading universities and researchers, including the use of the psychedelic drugs. The presentation will also feature a summary of Silo’s the diversified pipeline, which is focused on underserved rare disease,…

Continue Reading

ThursdayOct 06, 2022 12:59 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Issues Recap of Concussion Drug Development Program

Odyssey Health (OTC: ODYY), a company focused on developing unique, life-saving medical products, today provided a recap of its concussion drug development program. Concussions affect millions worldwide and represent an ‘unmet’ medical need, while repetitive concussions can increase the risk of developing chronic traumatic encephalopathy (“CTE”) and other neuropsychiatric disorders. Since acquisition of the intellectual property and all rights to the drug on March 1, 2021, Odyssey has made significant progress in its development program. Among many key milestones provided in the update, the company announced successful completion of the pre-clinical toxicology program and IND enabling safety studies for a…

Continue Reading

ThursdayOct 06, 2022 12:40 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Platform to Add 24/7 Heart Monitoring Capability

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, today announced the expansion of its product portfolio pipeline to serve the growing cardiac device wearable technology market by bringing clinically relevant diagnostic information to patients and clinicians. According to the update, the product pipeline advancement allows for the addition of arrhythmia detection capabilities to address the multibillion global market for atrial fibrillation and other arrhythmia monitoring. “Adding smartwatch connectivity to our platform is a significant development as it extends our portfolio by enabling 24/7 heart monitoring…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered